首页> 外文期刊>Current medical research and opinion >Erectile dysfunction with or without coexisting benign prostatic hyperplasia in the general US population: Analysis of US National Health and Wellness Survey
【24h】

Erectile dysfunction with or without coexisting benign prostatic hyperplasia in the general US population: Analysis of US National Health and Wellness Survey

机译:在美国普通人群中有或没有并存良性前列腺增生的勃起功能障碍:美国国家健康调查的分析

获取原文
获取原文并翻译 | 示例
       

摘要

Objective: Erectile dysfunction (ED) and benign prostatic hyperplasia (BPH) commonly affect older men. There is limited epidemiology information on coexisting ED and BPH. This study assessed self-reported prevalence of ED with or without a diagnosis of BPH (ED/DxBPH versus ED only) in US men. Methods: Men ≥40 years old, who reported experiencing ED in the past 6 months with or without a diagnosis of BPH, were identified from the nationally representative 2011 US National Health and Wellness Survey (NHWS)-a cross-sectional, self-administered online survey. Unpaired t-tests were used to compare characteristics between ED-only and ED/DxBPH populations. Results: The prevalence of ED only and ED/DxBPH was 24.6% and 4.9% (mean ages of 60 and 68 years, respectively). About two-thirds of those with ED only and ED/DxBPH reported speaking to their physician about ED. About 23% of either group reported currently using ED medication and 11.7% of men with ED only were prescribed ED medication by a urologist, compared to 31.1% with ED/DxBPH. Approximately 51.7% of men with ED/DxBPH were taking BPH medication. Overall, 37.3% of men with ED only and 74.6% with ED/DxBPH reported moderate-to-severe urinary symptoms on the American Urological Association-Symptom Index (AUA-SI ≥8). Conclusion: While self-reported ED is common, few men with ED in the US population report being diagnosed with BPH. The majority of ED only and ED/DxBPH men reported speaking to a physician about ED; however, few reported currently taking ED medication. A majority of men with ED/DxBPH reported an AUA-SI score ≥8, but only half reported taking BPH medications. Thus, although men are experiencing erectile or urinary symptoms, many remain untreated. A limitation of this study is that symptoms and diagnosis were self-reported and may not reflect how these conditions are diagnosed in a healthcare setting; however, patient self-report provides a unique perspective on the burden associated with these conditions.
机译:目的:勃起功能障碍(ED)和良性前列腺增生(BPH)通常会影响老年男性。关于ED和BPH并存的流行病学信息有限。这项研究评估了美国男性自我报告的ED患病率,无论有无BPH诊断(ED / DxBPH与仅ED)。方法:从具有全国代表性的2011年美国国民健康与健康调查(NHWS)中识别出年龄≥40岁的男性,在过去的6个月中曾报告过ED,无论是否诊断为BPH。在线调查。未配对的t检验用于比较仅ED人群和ED / DxBPH人群之间的特征。结果:仅ED和ED / DxBPH的患病率为24.6%和4.9%(平均年龄分别为60岁和68岁)。仅患有ED和ED / DxBPH的患者中约有三分之二报告曾就其ED向其医生讲话。两组中约有23%的人报告目前正在使用ED药物,而只有ED的男性中有11.7%的泌尿科医师处方了ED药物,而ED / DxBPH则为31.1%。约51.7%的ED / DxBPH男性正在服用BPH药物。总体而言,只有ED的男性中有37.3%,ED / DxBPH的男性中有74.6%在美国泌尿科协会症状指数(AUA-SI≥8)上报告了中度至重度尿路症状。结论:尽管自我报告的ED很常见,但美国人群中很少有ED男性报告被诊断为BPH。多数仅ED和ED / DxBPH男性报告与医生谈论ED。但是,很少有报道称目前正在服用ED药物。 ED / DxBPH的大多数男性报告其AUA-SI得分≥8,但只有半数报告服用BPH药物。因此,尽管男性正经历勃起或泌尿系统症状,但许多人仍未得到治疗。该研究的局限性在于症状和诊断是自我报告的,可能无法反映出在医疗机构中如何诊断这些疾病;然而,患者的自我报告提供了与这些疾病相关的负担的独特视角。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号